Exact Sciences to Participate in November Investor Conference
01 November 2024 - 9:00PM
Business Wire
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of
cancer screening and diagnostic tests, today announced that company
management will participate in the following conference and invited
investors to participate by webcast.
- Jefferies London Healthcare Conference, London Fireside chat on
Tuesday, November 19, 2024 at 6:00 a.m. ET
The webcast can be accessed in the investor relations section of
Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests,
Exact Sciences gives patients and health care professionals the
clarity needed to take life-changing action earlier. Building on
the success of the Cologuard® and Oncotype® tests, Exact Sciences
is investing in its pipeline to develop innovative solutions for
use before, during, and after a cancer diagnosis. For more
information, visit ExactSciences.com, follow Exact Sciences on X
@ExactSciences, or find Exact Sciences on
LinkedIn and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241101637242/en/
Erik Holznecht Exact Sciences Corp.
investorrelations@exactsciences.com 608-800-6605
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Oct 2024 to Nov 2024
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Nov 2023 to Nov 2024
